Diabetes

LAS VEGAS — Walgreens’ increasing use of mobile technology platforms is transforming the way the company reaches patients and is expanding its ability to deliver health services via smart phones and other devices, a Walgreens official asserted Friday.

Speaking at the opening of the Consumer Electronics Show’s Digital Health Summit this morning, Walgreens chief medical officer Cheryl Pegus laid out the ways the health services and retail pharmacy giant is leveraging technology to make personal health management easier for patients.

PRINCETON, N.J. — A new oral treatment for Type 2 diabetes hit the shelves Friday.

Bristol-Myers Squibb and AstraZeneca announced the availability of Kombiglyze XR (saxagliptin and metformin hydrochloride), which the companies called the only once-daily treatment for diabetes that combined metformin with a DPP-4 inhibitor, the drug class to which saxagliptin belongs.

The drug is designed for use alongside diet and exercise to improve glycemic control in adults with Type 2 diabetes.

WOONSOCKET, R.I. — Patients with one or more out of four chronic diseases studied who take their medications as prescribed may save the healthcare system as much as $7,800 per patient annually, according to findings of a new CVS Caremark study analyzing annual pharmacy and medical costs over a three-year period.

HARRISBURG, Pa. — Bayer Diabetes’ Contour USB, pictured here at CVS, may be ideal for those tech-savvy boomers just learning they have diabetes. 

The monitor takes a blood-glucose reading at one end and can be inserted into the USB port of either a home computer or the laptop in the doctor’s office.

MIAMI — With new leadership at the helm, Navarro Discount Pharmacy continues its goal of catering to the needs of the Hispanic community in the Miami area. Navarro is the largest Hispanic-owned drug store chain in the United States, with 28 locations that cater to the Hispanic market through their product offerings and services.


The company, which garnered about $320 million in sales in 2009, tapped in late 2009 former Bigg’s executive Steve Kaczynski to serve as CEO, and has since further bolstered its management team as part of its expansion strategy.


Pharmacists who intervene with diabetes patients are having a clear and positive impact on clinical outcomes, a new study from Walgreens found.


In a presentation last month, two Walgreens healthcare leaders unveiled the results of a groundbreaking pilot project on pharmacy-based diabetic care. Walgreens launched the project, called Dimensions, at its worksite pharmacies in 2008.



Sales of diet-aid and weight-loss solutions for the past year have been relatively flat, but a confluence of factors — childhood obesity approaching “epidemic” status combined with the real need to reduce escalating healthcare costs connected to obesity — could become a real driver behind weight-loss products in the coming year. 


ALEXANDRIA, Va. — The National Association of Chain Drug Stores Foundation is inviting health and pharmacy experts and other researchers to join the Herculean effort to improve patient adherence rates.

The invitation comes in the form of a new Request for Proposal, issued Tuesday by the NACDS Foundation. The foundation is seeking bids from research organizations to study primary medication nonadherence, which occurs when a patient fails to fill or pick up his or her newly prescribed medication.